Tufaro Francis 4
4 · Theriva Biologics, Inc. · Filed Dec 16, 2022
Insider Transaction Report
Form 4
Tufaro Francis
Chief Operating Officer
Transactions
- Award
Stock Options (right to buy)
2022-12-15+100,000→ 100,000 totalExercise: $0.58From: 2023-01-15Exp: 2029-12-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 36 months.